secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMYRIS, INC. (—)
CIK:        0001365916
Form:       8-K
Filed at:   2023-04-04T23:59:59+00:00
Accession:  0001365916-23-000034
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Amyris closes $200M asset sale to Givaudan, buys remaining 49% of Aprinnova for $49M
--------------------------------------------------------------------------------

- Sold cosmetic ingredients assets to Givaudan for $200M upfront cash plus up to $150M performance earnout over three years.
- Total estimated value including near- and long-term manufacturing partnership is approximately $500M.
- Purchased 49% of Aprinnova from Nikko Chemicals and Nissa for $49M cash, increasing Amyris ownership to 99%.
- Both transactions closed on April 3, 2023, as previously announced.
- Long-term partnership with Givaudan for Amyris to manufacture cosmetic ingredients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1365916/000136591623000034/0001365916-23-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1365916/000136591623000034/amrs-20230403.htm
  HTML page:      https://secwatch.observer/filing/0001365916-23-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer